| A rapid, inexpensive and disposable point‐of‐care blood test for sickle cell disease using novel, highly specific monoclonal antibodies CT Quinn, MC Paniagua, RK DiNello, A Panchal, M Geisberg British journal of haematology 175 (4), 724-732, 2016 | 69 | 2016 |
| COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors A Panchal, P Seto, R Wall, BJ Hillier, Y Zhu, J Krakow, A Datt, E Pongo, ... MAbs 12 (1), 1792130, 2020 | 37 | 2020 |
| Tritacs, a novel class of t-cell–engaging protein constructs designed for the treatment of solid tumors RJ Austin, BD Lemon, WH Aaron, M Barath, PA Culp, RB DuBridge, ... Molecular Cancer Therapeutics 20 (1), 109-120, 2021 | 28 | 2021 |
| Inducible binding proteins and methods of use P Baeuerle, RB Dubridge, H Wesche, L Evnin, J Guenot, A Panchal, ... US Patent App. 15/727,423, 2018 | 28 | 2018 |
| The RpoE stress response pathway mediates reduction of the virulence of enteropathogenic Escherichia coli by zinc Y Xue, J Osborn, A Panchal, JL Mellies Applied and Environmental Microbiology 81 (11), 3766-3774, 2015 | 17 | 2015 |
| Monoclonal antibody-mediated detection of CTX-M β-lactamases in Gram-negative bacteria NJ Tarlton, TS Satoorian, A Panchal, CA Borges, M Geisberg, LW Riley Journal of microbiological methods 144, 37-43, 2018 | 11 | 2018 |
| Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186 DE Dettling, E Kwok, L Quach, A Datt, JD Degenhardt, A Panchal, P Seto, ... Journal for Immunotherapy of Cancer 10 (6), 2022 | 6 | 2022 |
| Constrained conditionally activated binding proteins C May, RB Dubridge, M Vinogradova, A Panchal US Patent App. 16/810,770, 2020 | 6 | 2020 |
| CONDITIONALLY ACTIVATED BINDING PROTEINS CONTAINING Fc REGIONS AND MOIETIES TARGETING TUMOR ANTIGENS RB Dubridge, A Panchal US Patent App. 17/435,931, 2022 | 3 | 2022 |
| COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. mAbs 12: 1792130 A Panchal, P Seto, R Wall, BJ Hillier, Y Zhu, J Krakow, A Datt, E Pongo, ... | 3 | 2020 |
| Constrained conditionally activated binding proteins C May, RB Dubridge, M Vinogradova, A Panchal US Patent 11,744,892, 2023 | 2 | 2023 |
| Constrained conditionally activated binding proteins C May, RB Dubridge, M Vinogradova, A Panchal US Patent 11,744,893, 2023 | 2 | 2023 |
| COBRA: A novel conditionally active bispecific antibody that regresses established solid tumors in mice D Dettling, E Kwok, L Quach, A Datt, JD Degenhardt, M Vinogradova, ... Cancer Research 79 (13_Supplement), 557-557, 2019 | 2 | 2019 |
| Constrained conditionally activated binding proteins C May, RB Dubridge, M Vinogradova, A Panchal US Patent App. 18/356,985, 2024 | | 2024 |
| Constrained conditionally activated binding proteins C May, RB BuBridge, M Vinogradova, A Panchal US Patent App. 18/357,013, 2023 | | 2023 |
| Single domain antigen binding domains that bind human Trop2 C May, RB Dubridge, M Vinogradova, A Panchal US Patent 11,685,780, 2023 | | 2023 |
| INDUCTIBLE BINDING PROTEINS AND METHODS OF USE P Baeuerle, RB Dubridge, H Wesche, L Evnin, J Guenot, A Panchal, ... | | 2020 |
| COBRA: A novel conditionally active bispecific antibody that regresses established solid tumors in mice A Panchal, A Bagheri, M Vinogradova, T Chen, R Wall, S Levon, P Seto, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
| Protéines de liaison inductibles et méthodes d'utilisation P Baeuerle, RB Dubridge, L Evnin, J Guenot, A Panchal, M Vinogradova, ... | | 2018 |
Patrick A. BaeuerleCullinan TherapeuticsVerified email at cullinanoncology.com
